ADID, Inc.
ADID, Inc. is developing investigational monitoring technology for people living with spinal cord injury.
Detailed product, platform, and study information is not currently published on this site. Enquiries are welcome by email.
ADID has not been cleared or approved by the U.S. Food and Drug Administration or any other regulatory authority. No claim of safety, effectiveness, diagnostic accuracy, or clinical benefit is made. ADID is not offered for sale and is not available for general distribution. Nothing on this site is medical advice.
No study is open to enrollment, and no participants are being recruited or screened. This site does not enroll participants. If a study opens in the future, enrollment will take place through participating clinical sites under an approved informed-consent process.
Contact
General: info@adid.app
Privacy and data requests: privacy@adid.app